BP
Bhaskarreddy Pabbatireddy
About Bhaskarreddy Pabbatireddy
Data last updated:
Bhaskarreddy Pabbatireddy is a Director at Annora Pharma Private Limited (since 2020), Additional Director at Aspiro Pharma Limited (since 2025) and Additional Director at Hetero Biopharma Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹2,305 Cr; the largest is Annora Pharma Private Limited at ₹1,494 Cr (FY 2025). Earlier, Bhaskarreddy Pabbatireddy was a Director at Evaric Pharma Private Limited (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Annora Pharma Private Limited U24100TG2015PTC101939 | Director | 05 Mar 2020 | 2015 | ₹1,494 Cr (FY 2025) | Active |
 Aspiro Pharma Limited U24100TG2014PLC092771 | Additional Director | 10 Oct 2025 | 2014 | ₹418 Cr (FY 2025) | Active |
 Hetero Biopharma Limited U24290TG2016PLC111946 | Additional Director | 26 Sep 2025 | 2016 | ₹387 Cr (FY 2024) | Active |
| Hetero Plasma Sciences Private Limited U46497TS2023PTC175917 | Director | 01 Mar 2024 | 2023 | ₹4.83 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Evaric Pharma Private Limited U24100TG2015PTC102128 | Director | 08 Dec 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bhaskarreddy Pabbatireddy
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhaskarreddy Pabbatireddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhaskarreddy Pabbatireddy
Bhaskarreddy Pabbatireddy currently holds 4 directorships: Annora Pharma Private Limited (Director, since 05 Mar 2020, revenue ₹1,494 Cr (FY 2025)); Aspiro Pharma Limited (Additional Director, since 10 Oct 2025, revenue ₹418 Cr (FY 2025)); Hetero Biopharma Limited (Additional Director, since 26 Sep 2025, revenue ₹387 Cr (FY 2024)); Hetero Plasma Sciences Private Limited (Director, since 01 Mar 2024, revenue ₹4.83 Cr (FY 2025)).
Bhaskarreddy Pabbatireddy was first appointed on 08 Dec 2015 as Director at Evaric Pharma Private Limited. The most recent appointment on record is 10 Oct 2025 at Aspiro Pharma Limited.
The 4 current companies of Bhaskarreddy Pabbatireddy that report revenue have a combined latest revenue of ₹2,305 Cr: Annora Pharma Private Limited ₹1,494 Cr (FY 2025); Aspiro Pharma Limited ₹418 Cr (FY 2025); Hetero Biopharma Limited ₹387 Cr (FY 2024); Hetero Plasma Sciences Private Limited ₹4.83 Cr (FY 2025).
Bhaskarreddy Pabbatireddy held 1 earlier board appointment: Evaric Pharma Private Limited (Director, from 08 Dec 2015).
The current boards of Bhaskarreddy Pabbatireddy's companies include Bandi Venkatarami Reddy (Annora Pharma Private Limited), Govindaraju Bhavani (Annora Pharma Private Limited), Kiran Kumar Manikwar (Annora Pharma Private Limited), Mahesh Ramappa Kamalamma Hassan (Annora Pharma Private Limited), Palleswara Rao Palapatla Govada (Annora Pharma Private Limited), Sridhar Reddy Badduri (Annora Pharma Private Limited), among others.